Contract Manufacturing

For over a decade, D.B.M. has been committed to researching and developing new medical devices for various clinical applications, including gynaecology, aesthetics and orthopaedics. Its primary objective is to successfully fulfil the business development process of its Italian and international customers.

The production facility

The production activities are organised over a total area of more than 5,000 square metres. Just a stone’s throw from the historical site, the new facility is equipped with a modern preparation room, and high-quality clean rooms where processes including moist-heat terminal sterilisation are carried out.

D.B.M. also offers support for customer projects requiring gamma terminal sterilisation.

Syringe and bottle filling

D.B.M.’s filling business encompasses a wide range of materials:

  • glass syringes and bottles from 1 ml to 10 ml
  • syringes in various plastic polymers, including PP, COC and COP.

The company has a total production capacity of up to 20 million pieces per year, with filling volumes per unit of 0.5 ml to 60 ml.

A team of professionals ready to meet customers' needs

D.B.M. employs a workforce of more than 40 highly skilled professionals across various departments, including the Production, Research and Development, Preparation Room, Quality, Regulatory Affairs, Validation and Technical departments.

It harnesses this expertise to collaborate actively with its customers, from the initial idea through to the final stage of registering the medical device, including drafting the Instructions for Use and managing clinical trials.

D.B.M.’s added value for your project

D.B.M. adds unparalleled value to its customers’ projects.

It draws on its extensive experience to execute your project flawlessly on a contract manufacturing basis, guaranteeing the utmost quality while strictly complying with industry regulations.

Ask for information

INFORMATION PURSUANT TO ART. 13 AND 14 OF EU REGULATION 2016/679 (GDPR): The personal data acquired will be used by DBM Srl, Via dell'Industria, 2 - 23030 Tovo di Sant'Agata (SO), also with the aid of electronic and/or automated means, exclusively to respond to the request made. The data subject may exercise all rights enshrined in Articles 15- 22 of the GDPR by writing to Data sent to us will not be disclosed and/or transmitted to third parties and will be kept by DBM Srl for a maximum period of two years.

The pages of this website are intended for health professionals only.

The information they contain is to be understood as intended for these users only. Therefore, to visit these pages, I hereby declare under my own responsibility that I belong to the aforementioned professional category.

With reference to the supplement to the circular of 23/03/2006, issued on 20/04/2010 by the Italian Ministry of Health, concerning the advertising of medical devices, only doctors, pharmacists and other health professionals may consult the contents of this website.

1. Information.

This website contains information intended solely for medical doctors and health professionals. D.B.M. Srl shall not be held liable for access by third parties to the information pages for health professionals as specified above. The medical device descriptions presented on these pages are for information purposes only and are not for advertising purposes. The information on this website is of a general nature and is not an alternative to seeking appropriate medical treatment, nor is it intended to advertise any medical procedures. Patients should speak to their doctor to assess treatment options, risks and benefits.

2.  Links.

All links on this website are provided for your convenience only. D.B.M. Srl accepts no responsibility for the contents of third-party websites. With regard to the links on its website, D.B.M. Srl expressly excludes any intentions other than that of merely providing information.

3.  Intellectual property.

All text, images, drawings and attachments are the exclusive property of D.B.M. Srl. Anyone using them improperly or without authorisation will be prosecuted.